• Title of article

    Intronic SH2D1A mutation with impaired SAP expression and agammaglobulinemia

  • Author/Authors

    Recher، نويسنده , , Mike and Fried، نويسنده , , Ari J. and Massaad، نويسنده , , Michel J. and Kim، نويسنده , , Hye Young and Rizzini، نويسنده , , Michela and Frugoni، نويسنده , , Francesco and Walter، نويسنده , , Jolan E. and Mathew، نويسنده , , Divij and Eibel، نويسنده , , Hermann and Hess، نويسنده , , Christoph and Giliani، نويسنده , , Silvia and Umetsu، نويسنده , , Dale T. and Notarangelo، نويسنده , , Lui، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2013
  • Pages
    6
  • From page
    84
  • To page
    89
  • Abstract
    X-linked lymphoproliferative (XLP) disease is a primary immunodeficiency syndrome associated with the inability to control Epstein-Barr virus (EBV), lymphoma, and hypogammaglobulinemia. XLP is caused by mutations in the SH2D1A gene, which encodes the SLAM-associated protein (SAP), or in the BIRC4 gene, which encodes the X-linked inhibitor of apoptosis protein (XIAP). e report a patient with recurrent respiratory tract infections and early onset agammaglobulinemia who carried a unique disease-causing intronic loss-of-function mutation in SH2D1A. The intronic mutation affected SH2D1A gene transcription but not mRNA splicing, and led to markedly reduced level of SAP protein. Despite undetectable serum immunoglobulins, the patientʹs B cells replicated and differentiated into antibody producing cells normally in vitro.
  • Keywords
    EBV , agammaglobulinemia , X-linked lymphoproliferative disease , B cells , SAP
  • Journal title
    Clinical Immunology
  • Serial Year
    2013
  • Journal title
    Clinical Immunology
  • Record number

    1856085